Charles Schwab Investment Management Inc Nuvalent, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Nuvalent, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 265,291 shares of NUVL stock, worth $27.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
265,291
Previous 242,044
9.6%
Holding current value
$27.3 Million
Previous $18.2 Million
10.72%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding NUVL
# of Institutions
178Shares Held
56.6MCall Options Held
527KPut Options Held
131K-
Deerfield Management Company, L.P. (Series C) New York, NY20MShares$2.06 Billion31.83% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.57MShares$471 Million14.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.78MShares$389 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$311 Million0.01% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.7MShares$278 Million41.86% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $4.43B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...